{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:33:24Z","timestamp":1790728404175,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,11,3]],"date-time":"2014-11-03T00:00:00Z","timestamp":1414972800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,11,3]],"date-time":"2014-11-03T00:00:00Z","timestamp":1414972800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1038\/leu.2014.310","type":"journal-article","created":{"date-parts":[[2014,11,3]],"date-time":"2014-11-03T07:35:47Z","timestamp":1415000147000},"page":"939-946","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["IL-35 mitigates murine acute graft-versus-host disease with retention of graft-versus-leukemia effects"],"prefix":"10.1038","volume":"29","author":[{"given":"Y","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D A A","family":"Vignali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,3]]},"reference":[{"key":"BFleu2014310_CR1","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1098\/rstb.2005.1701","volume":"360","author":"BR Blazar","year":"2005","unstructured":"Blazar BR, Murphy WJ . Bone marrow transplantation and approaches to avoid graft-versus-host disease (GVHD). Philos Trans R Soc Lond B Biol Sci 2005; 360: 1747\u20131767.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"BFleu2014310_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1053\/j.seminhematol.2005.09.001","volume":"43","author":"JL Ferrara","year":"2006","unstructured":"Ferrara JL, Reddy P . Pathophysiology of graft-versus-host disease. Semin Hematol 2006; 43: 3\u201310.","journal-title":"Semin Hematol"},{"key":"BFleu2014310_CR3","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nri2000","volume":"7","author":"WD Shlomchik","year":"2007","unstructured":"Shlomchik WD . Graft-versus-host disease. Nat Rev Immunol 2007; 7: 340\u2013352.","journal-title":"Nat Rev Immunol"},{"key":"BFleu2014310_CR4","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nri1032","volume":"3","author":"JA Bluestone","year":"2003","unstructured":"Bluestone JA, Abbas AK . Natural versus adaptive regulatory T cells. Nat Rev Immunol 2003; 3: 253\u2013257.","journal-title":"Nat Rev Immunol"},{"key":"BFleu2014310_CR5","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1172\/JCI23411","volume":"114","author":"H Jiang","year":"2004","unstructured":"Jiang H, Chess L . An integrated view of suppressor T cell subsets in immunoregulation. J Clin Invest 2004; 114: 1198\u20131208.","journal-title":"J Clin Invest"},{"key":"BFleu2014310_CR6","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.immuni.2006.08.003","volume":"25","author":"EM Shevach","year":"2006","unstructured":"Shevach EM . From vanilla to 28 flavors: multiple varieties of T regulatory cells. Immunity 2006; 25: 195\u2013201.","journal-title":"Immunity"},{"key":"BFleu2014310_CR7","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1084\/jem.193.11.1311","volume":"193","author":"PA Taylor","year":"2001","unstructured":"Taylor PA, Noelle RJ, Blazar BR . CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. J Exp Med 2001; 193: 1311\u20131318.","journal-title":"J Exp Med"},{"key":"BFleu2014310_CR8","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/ni1178","volume":"6","author":"S Sakaguchi","year":"2005","unstructured":"Sakaguchi S . Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 2005; 6: 345\u2013352.","journal-title":"Nat Immunol"},{"key":"BFleu2014310_CR9","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1084\/jem.20020090","volume":"196","author":"JL Cohen","year":"2002","unstructured":"Cohen JL, Trenado A, Vasey D, Klatzmann D, Salomon BL . CD4(+)CD25(+) immuno- regulatory T Cells: new therapeutics for graft-versus-host disease. J Exp Med 2002; 196: 401\u2013406.","journal-title":"J Exp Med"},{"key":"BFleu2014310_CR10","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1084\/jem.20020399","volume":"196","author":"P Hoffmann","year":"2002","unstructured":"Hoffmann P, Ermann J, Edinger M, Fathman CG, Strober S . Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J Exp Med 2002; 196: 389\u2013399.","journal-title":"J Exp Med"},{"key":"BFleu2014310_CR11","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1053\/bbmt.2002.v8.pm12434947","volume":"8","author":"BD Johnson","year":"2002","unstructured":"Johnson BD, Konkol MC, Truitt RL . CD25+ immunoregulatory T-cells of donor origin suppress alloreactivity after BMT. Biol Blood Marrow Transplant 2002; 8: 525\u2013535.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFleu2014310_CR12","doi-asserted-by":"publisher","first-page":"3493","DOI":"10.1182\/blood.V99.10.3493","volume":"99","author":"PA Taylor","year":"2002","unstructured":"Taylor PA, Lees CJ, Blazar BR . The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. Blood 2002; 99: 3493\u20133499.","journal-title":"Blood"},{"key":"BFleu2014310_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/bmt.2009.328","volume":"45","author":"S Paczesny","year":"2010","unstructured":"Paczesny S, Hanauer D, Sun Y, Reddy P . New perspectives on the biology of acute GVHD. Bone Marrow Transplant 2010; 45: 1\u201311.","journal-title":"Bone Marrow Transplant"},{"key":"BFleu2014310_CR14","doi-asserted-by":"publisher","first-page":"12041","DOI":"10.1073\/pnas.94.22.12041","volume":"94","author":"O Devergne","year":"1997","unstructured":"Devergne O, Birkenbach M, Kieff E . Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin. Proc Natl Acad Sci USA 1997; 94: 12041\u201312046.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2014310_CR15","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/nature06306","volume":"450","author":"LW Collison","year":"2007","unstructured":"Collison LW, Workman CJ, Kuo TT, Boyd K, Wang Y, Vignali KM et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 2007; 450: 566\u2013569.","journal-title":"Nature"},{"key":"BFleu2014310_CR16","doi-asserted-by":"publisher","first-page":"6121","DOI":"10.4049\/jimmunol.0803646","volume":"182","author":"LW Collison","year":"2009","unstructured":"Collison LW, Pillai MR, Chaturvedi V, Vignali DA . Regulatory T cell suppression is potentiated by target T cells in a cell contact, IL-35- and IL-10-dependent manner. J Immunol 2009; 182: 6121\u20136128.","journal-title":"J Immunol"},{"key":"BFleu2014310_CR17","doi-asserted-by":"publisher","first-page":"5590","DOI":"10.4049\/jimmunol.1201744","volume":"189","author":"BM Olson","year":"2012","unstructured":"Olson BM, Jankowska-Gan E, Becker JT, Vignali DA, Burlingham WJ, McNeel DG . Human prostate tumor antigen-specific CD8+ regulatory T cells are inhibited by CTLA-4 or IL-35 blockade. J Immunol 2012; 189: 5590\u20135601.","journal-title":"J Immunol"},{"key":"BFleu2014310_CR18","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/nature12979","volume":"507","author":"P Shen","year":"2014","unstructured":"Shen P, Roch T, Lampropoulou V, O'Connor RA, Stervbo U, Hilgenberg E et al. IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases. Nature 2014; 507: 366\u2013370.","journal-title":"Nature"},{"key":"BFleu2014310_CR19","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/ni.1952","volume":"11","author":"LW Collison","year":"2010","unstructured":"Collison LW, Chaturvedi V, Henderson AL, Giacomin PR, Guy C, Bankoti J et al. IL-35-mediated induction of a potent regulatory T cell population. Nat Immunol 2010; 11: 1093\u20131101.","journal-title":"Nat Immunol"},{"key":"BFleu2014310_CR20","doi-asserted-by":"publisher","first-page":"7144","DOI":"10.4049\/jimmunol.0902739","volume":"184","author":"I Kochetkova","year":"2010","unstructured":"Kochetkova I, Golden S, Holderness K, Callis G, Pascual DW . IL-35 stimulation of CD39+ regulatory T cells confers protection against collagen II-induced arthritis via the production of IL-10. J Immunol 2010; 184: 7144\u20137153.","journal-title":"J Immunol"},{"key":"BFleu2014310_CR21","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1002\/eji.200737810","volume":"37","author":"W Niedbala","year":"2007","unstructured":"Niedbala W, Wei XQ, Cai B, Hueber AJ, Leung BP, McInnes IB et al. IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur J Immunol 2007; 37: 3021\u20133029.","journal-title":"Eur J Immunol"},{"key":"BFleu2014310_CR22","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1182\/blood.V88.8.3230.bloodjournal8883230","volume":"88","author":"KR1 Cooke","year":"1996","unstructured":"Cooke KR1, Kobzik L, Martin TR, Brewer J, Delmonte J Jr, Crawford JM et al. An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin. Blood 1996; 88: 3230\u20133239.","journal-title":"Blood"},{"key":"BFleu2014310_CR23","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1182\/blood.V90.8.3204","volume":"90","author":"GR Hill","year":"1997","unstructured":"Hill GR, Crawford JM, Cooke KR, Brinson YS, Pan L, Ferrara JL . Total body irra-diation and acute graft-versus-host disease: the role of gastrointestinal damageand inflammatory cytokines. Blood 1997; 90: 3204\u20133213.","journal-title":"Blood"},{"key":"BFleu2014310_CR24","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1172\/JCI4285","volume":"102","author":"KR1 Cooke","year":"1998","unstructured":"Cooke KR1, Hill GR, Crawford JM, Bungard D, Brinson YS, Delmonte J Jr et al. Tumor necrosis factor-alpha production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease. J Clin Invest 1998; 102: 1882\u20131891.","journal-title":"J Clin Invest"},{"key":"BFleu2014310_CR25","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1038\/nm1463","volume":"12","author":"JL Zakrzewski","year":"2006","unstructured":"Zakrzewski JL, Kochman AA, Lu SX, Terwey TH, Kim TD, Hubbard VM et al. Adoptive transfer of T-cell precursors enhances T-cell reconstitution after allogeneic hematopoietic stem cell transplantation. Nat Med 2006; 12: 1039\u20131047.","journal-title":"Nat Med"},{"key":"BFleu2014310_CR26","doi-asserted-by":"publisher","first-page":"464","DOI":"10.4049\/jimmunol.1200886","volume":"189","author":"AJ Beres","year":"2012","unstructured":"Beres AJ, Haribhai D, Chadwick AC, Gonyo PJ, Williams CB, Drobyski WR . CD8+ Foxp3+ regulatory T cells are induced during graft-versus-host disease and mitigate disease severity. J Immunol 2012; 189: 464\u2013474.","journal-title":"J Immunol"},{"key":"BFleu2014310_CR27","doi-asserted-by":"publisher","first-page":"5898","DOI":"10.1182\/blood-2011-12-396119","volume":"119","author":"RJ Robb","year":"2012","unstructured":"Robb RJ, Lineburg KE, Kuns RD, Wilson YA, Raffelt NC, Olver SD et al. Identification and expansion of highly suppressive CD8(+)FoxP3(+) regulatory T cells after experimental allogeneic bone marrow transplantation. Blood 2012; 119: 5898\u20135908.","journal-title":"Blood"},{"key":"BFleu2014310_CR28","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/sj.bmt.1705218","volume":"37","author":"LE Weston","year":"2006","unstructured":"Weston LE, Geczy AF, Briscoe H . Production of IL-10 by alloreactive sibling donor cells and its influence on the development of acute GVHD. Bone Marrow Transplant 2006; 37: 207\u2013212.","journal-title":"Bone Marrow Transplant"},{"key":"BFleu2014310_CR29","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2011.03.018","volume":"34","author":"A Chaudhry","year":"2011","unstructured":"Chaudhry A, Samstein RM, Treuting P, Liang Y, Pils MC, Heinrich JM et al. Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. Immunity 2011; 34: 566\u2013578.","journal-title":"Immunity"},{"key":"BFleu2014310_CR30","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.immuni.2011.01.020","volume":"34","author":"S Huber","year":"2011","unstructured":"Huber S, Gagliani N, Esplugues E, O'Connor W Jr, Huber FJ, Chaudhry A et al. Th17 cells express interleukin-10 receptor and are controlled by Foxp3(-) and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner. Immunity 2011; 34: 554\u2013565.","journal-title":"Immunity"},{"key":"BFleu2014310_CR31","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1182\/blood-2007-12-126987","volume":"112","author":"T Yi","year":"2008","unstructured":"Yi T, Zhao D, Lin CL, Zhang C, Chen Y, Todorov I et al. Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease. Blood 2008; 112: 2101\u20132110.","journal-title":"Blood"},{"key":"BFleu2014310_CR32","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1182\/blood-2008-08-172155","volume":"113","author":"LW Kappel","year":"2009","unstructured":"Kappel LW, Goldberg GL, King CG, Suh DY, Smith OM, Ligh C et al. IL-17 contributes to CD4-mediated graft-versus-host disease. Blood 2009; 113: 945\u2013952.","journal-title":"Blood"},{"key":"BFleu2014310_CR33","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.bbmt.2009.09.023","volume":"16","author":"C Iclozan","year":"2010","unstructured":"Iclozan C, Yu Y, Liu C, Liang Y, Yi T, Anasetti C et al. T helper17 cells are sufficient but not necessary to induce acute graft-versus-host disease. Biol Blood Marrow Transplant 2010; 16: 170\u2013178.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFleu2014310_CR34","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1097\/TP.0b013e3181bc267e","volume":"88","author":"E Dander","year":"2009","unstructured":"Dander E, Balduzzi A, Zappa G, Lucchini G, Perseghin P, Andre V et al. Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation. Transplantation 2009; 88: 1261\u20131272.","journal-title":"Transplantation"},{"key":"BFleu2014310_CR35","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1002\/eji.201040793","volume":"41","author":"XY Zhao","year":"2011","unstructured":"Zhao XY, Xu LL, Lu SY, Huang XJ . IL-17-producing T cells contribute to acute graft-versus-host disease in patients undergoing unmanipulated blood and marrow transplantation. Eur J Immunol 2011; 41: 514\u2013526.","journal-title":"Eur J Immunol"},{"key":"BFleu2014310_CR36","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1182\/blood-2009-12-255810","volume":"116","author":"P Ratajczak","year":"2010","unstructured":"Ratajczak P, Janin A, Peffault de Latour R, Leboeuf C, Desveaux A, Keyvanfar K et al. Th17\/Treg ratio in human graft-versus-host disease. Blood 2010; 116: 1165\u20131171.","journal-title":"Blood"},{"key":"BFleu2014310_CR37","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.bbmt.2012.11.018","volume":"19","author":"F Bahr","year":"2013","unstructured":"Bahr F, Wehner R, Platzbecker U, Wermke M, Shayegi N, Middeke JM et al. Reconstitution of interleukin-17-producing T helper cells after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2013; 19: 357\u2013365.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFleu2014310_CR38","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1038\/leu.2012.41","volume":"26","author":"C Bossard","year":"2012","unstructured":"Bossard C, Malard F, Arbez J, Chevallier P, Guillaume T, Delaunay J et al. Plasmacytoid dendritic cells and Th17 immune response contribution in gastrointestinal acute graft-versus-host disease. Leukemia 2012; 26: 1471\u20131474.","journal-title":"Leukemia"},{"key":"BFleu2014310_CR39","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1189\/jlb.0513295","volume":"94","author":"F Malard","year":"2013","unstructured":"Malard F, Bossard C, Brissot E, Chevallier P, Guillaume T, Delaunay J et al. Increased plasmacytoid dendritic cells and ROR\u03b3t-expressing immune effectors in cutaneous acute graft-versus-host disease. J Leukoc Biol 2013; 94: 1337\u20131343.","journal-title":"J Leukoc Biol"},{"key":"BFleu2014310_CR40","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nri775","volume":"2","author":"MR Van den Brink","year":"2002","unstructured":"Van den Brink MR, Burakoff SJ . Cytolytic pathways in haematopoietic stem-cell transplantation. Nat Rev Immunol 2002; 2: 273\u2013281.","journal-title":"Nat Rev Immunol"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2014310.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2014310","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2014310.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T16:08:42Z","timestamp":1648742922000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2014310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,3]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["BFleu2014310"],"URL":"https:\/\/doi.org\/10.1038\/leu.2014.310","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,3]]},"assertion":[{"value":"21 April 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"DAAV has submitted patents around IL-35 that are pending and is entitled to a share in net income generated from licensing of these patent rights for commercial development. The remaining authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}